ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

New NCI Grant Program Will Support Young Scientists In Innovative, “Risky” Research

May 27, 1977

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

DCE Advisors OK RFAs In Occupational Cancer, H. Pylori

April 1, 1994

Idaho Senator Pressure DeVita On Taking Neutron Facility

May 6, 1988

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994